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Background: Several studies have found that women who are 
overweight or obese have an increased risk of miscarriage. There is 
also some evidence of associations of other aspects of 
cardiometabolic health, including blood pressure and lipids, with 
miscarriage risk, although these have not been examined to the same 
extent as body-mass index (BMI). 
Methods: Our objective was to investigate the risk of miscarriage 
according to pre-pregnancy cardiometabolic health. We examined 
pre-pregnancy levels of BMI, blood pressure, fasting insulin and 
metabolites profile at age 18 and risk of miscarriage by age 24. The 
study included adult female offspring in the Avon Longitudinal Study 
of Parents and Children with a pregnancy between 18 and 24 years of 
age (n=434 for BMI and blood pressure; n=265 for metabolites). We 
used log-binomial regression to calculate adjusted associations 
between cardiometabolic health measures and miscarriage. 
Results: The overall risk of miscarriage was 22%.  The adjusted 
relative risks for miscarriage were 0.96 (95% CI: 0.92-1.00) for BMI (per 
unit increase), 0.98 (0.96-1.00) for systolic blood pressure, and 1.00 
(0.97-1.04) for diastolic blood pressure (per 1 mmHg increase).  Total 
cholesterol, total lipids and phospholipids in HDL-cholesterol were 
associated with increased likelihood of miscarriage, but none of the p-
values for the metabolites were below the corrected threshold for 
multiple testing (p-value ≤0.003). 
Conclusions: Our findings indicate no strong evidence to support a 
relationship between pre-pregnancy cardiometabolic health and risk 
of miscarriage in young, healthy women who became pregnant 
before age 24. Future studies are necessary that are able to evaluate 
this question in samples with a wider age range.
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          Amendments from Version 1
The revised version of the paper includes the following changes:
1. Expansion of the introduction to include more details of 
findings from previous studies.
2. We clearly state in the methods that we do not have 
information on gestational age of the miscarriages to verify that 
none of the reported miscarriages might have been a stillbirth.
3. We acknowledge that the confounders evaluated might have 
changed between when the information was obtained and the 
time of pregnancy.
4. We have included a new Table 1 which shows the distribution 
of background characteristics according to whether the woman 
experienced a miscarriage.
5. We have tempered the conclusion as requested by reviewers.
6. We have expanded on the limitations of the study focusing 
particularly on the potential influence on selection bias.
7. We have added a sensitivity analysis adjusting for the women’s 
mother’s report of miscarriages to account for heritability.






An estimated 12–15% of recognized pregnancies end in 
miscarriage1,2. Despite extensive research efforts, we know very 
little about its aetiology. It is believed that genetic components, 
including parental chromosomal rearrangements and abnor-
mal embryonic genotypes or karyotypes, explain about half of 
early miscarriages3. Risk of miscarriage is nonlinear in rela-
tion to women’s age; the risk is slightly higher in young women 
(<20 years), with a nadir of risk in the mid-20s, before an 
approximately linear increase from age 304.
Pre-pregnancy cardiometabolic health is likely to affect chances 
of conception as well as risk of fetal loss and may therefore be 
a key factor in ensuring a successful pregnancy5,6. Several studies 
have found that women who are overweight or obese have an 
increased risk of miscarriage, while others report a potential 
nonlinear relationship with an increased risk in underweight 
women as well7,8. There is conflicting evidence of a relation-
ship between blood pressure and risk of miscarriage, with one 
preconception cohort indicating a positive association with 
pregnancy loss9, while another study reported a lower blood 
pressure among women with a history of recurrent miscarriage10. 
The evidence of a relationship between lipid levels and risk of 
miscarriage is scarce. Animal studies support the notion that 
treatment of high cholesterol with statins may reduce the risk of 
miscarriage11.
The aim of the current study was to examine whether 
pre-pregnancy body-mass index (BMI), blood pressure, fasting 
insulin and metabolomic profile at age 18 are associated with 
miscarriage risk in young, healthy women who became 
pregnant before 24 years of age. The Avon Longitudinal Study of 
Parents and Children provided a unique opportunity to study this 
research question, since the adult offspring (also referred to as 
Generation 1, G1) of the women recruited to this pregnancy 
cohort in the 1990’s (G0) are now having their own children 
(G2), and their preconception cardiometabolic health has been 
extensively assessed.
Methods
Avon Longitudinal Study of Parents and Children
We studied female offspring (G1) participating in the Avon 
Longitudinal Study of Parents and Children (ALSPAC)12. Preg-
nant women (G0) resident in Avon, UK with expected deliv-
ery date between 1st of April 1991 and 31st of December 1992 
were invited to participate. The initial participation rate was 
estimated to be 75%, and a total of 14,541 pregnancies were 
enrolled into the cohort. There was a total of 14,676 fetuses, 
resulting in 14,062 live births and 13,988 children who were alive 
at 1 year of age. Information from participating mothers (G0) 
and their offspring (G1) were collected through self-completed 
questionnaires at regular intervals. G1 offspring were also 
invited to participate in regular clinical examinations from 
age 7 onwards. After age 22, study data were collected and 
managed using REDCap electronic data capture tools hosted 
at the University of Bristol13. The G1 generation have now 
reached an age where they are starting to have their own 
children. Figure 1 depicts the study design and generations 
in the ALSPAC cohort. The current study included 434 adult 
female offspring (G1) from the ALSPAC cohort who had a 
pregnancy by age 24 and from whom measures of cardiometa-
bolic health at 18 years of age were available (Extended data, 
Appendix 2)14. Ethical approval for the data collection in 
ALSPAC was obtained from the ALSPAC Ethics and Law 
Committee and the Local Research Ethics Committee. Patients 
or the public were not involved in the design, or conduct, or 
reporting, or dissemination plans of our research.
Measures of cardiometabolic health at 18 years of age
When G1 participants were an average of 18 years of age (SD 
0.4 years), they were invited to a comprehensive clinical exami-
nation that included blood sampling. Trained study nurses 
measured the participant’s height and weight, from which 
Figure  1.  Illustration  of  the  study  design  and  the  generations  included  in  the  Avon  Longitudinal  Study  of  Parents  and 
Children.
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we calculated their BMI (weight in kg/height in metres 
squared). Blood pressure (systolic and diastolic) was measured 
at least twice on the left arm. We used the mean systolic 
(SBP) and diastolic (DBP) blood pressure from the last two 
measurements taken with the DINAMAP 9301 machine as the 
exposures. 
Fasting (overnight or minimum of 6-hours) blood samples were 
immediately spun and frozen at -80°C. Comprehensive metabo-
lomic profiling was conducted at the University of Glasgow 
using a high-throughput proton nuclear magnetic resonance 
platform on an NMR spectometer. Two different pulse sequences 
are used. A 1D nuclear overhauser effect spectroscopy 
pulse sequence is used to detect lipoproteins. A Carr Purcell 
Meiboom Gill sequence is used to detect low-molecular-weight 
metabolites. This platform measures a total of 154 metabolomic 
traits, representing a broad range of signatures of systemic 
metabolism and 14 lipoprotein subclasses (particle concentra-
tion, lipid concentrations and composition), fatty acids and fatty 
acid compositions, amino acids, ketone bodies, glycolysis and 
glucogenesis-related metabolomic traits. The various metabolites 
that are part of the panel has been described in detail elsewhere15. 
We also included insulin as an exposure, which was measured 
separately from the metabolomics panel using an ELISA 
(Mercodia, Uppsala, Sweden) assay (catalogue number 10-1113-01) 
that does not cross react with proinsulin and plasma glucose. 
The read optical density was 450 nm.
Correlations between measures of cardiometabolic health at 
18 years of age (Extended data, Appendix 1)14 were in line with 
what we expected based on the literature16,17.
Identification of pregnancies and miscarriage by age 24
Information on whether participants had been pregnant, and 
the outcome of their pregnancies, was obtained by self-report 
at age 21, 22, 23, and 24. The outcome of any pregnancies 
were classified as “baby born alive”, “baby born stillborn”, 
“termination of an unwanted pregnancy”, “termination for 
medical reasons” and “miscarriage”. No additional informa-
tion on the gestational week when the pregnancy ended or the 
birthweight of the offspring was available to better distinguish 
between stillbirth and miscarriage. The outcome of interest was 
any miscarriage reported between age 18 and 24. The reference 
group consisted of all other pregnancy outcomes (including 
induced abortions).
Covariates
We identified potential confounders that could be associ-
ated with both cardiometabolic health and risk of miscarriage. 
This included age (continuous), smoking status (never, weekly, 
daily) and a marker of socioeconomic position at the time of the 
cardiometabolic assessment at age 18: whether the woman her-
self was “Not in Education, Employment or Training (NEET; 
yes versus no). Due to the young age of the women when their 
cardiometabolic health was assessed (age 18), they were mostly 
still in school, and information on their NEET status was there-
fore used as opposed to completed educational qualifications. 
However, we also considered the woman´s mother´s educational 
qualifications as a measure of family socio-economic position, 
categorized into low (CSE and vocational), medium (O or A 
level) and high (university degree).
Statistical analysis
We examined the evidence for a nonlinear relationship by 
comparing the log-likelihoods of models including tertiles of 
the measures of cardiometabolic health versus a single linear 
term. We estimated associations using log-binomial regression, 
reporting the relative risks (RR) for miscarriage per unit 
increase in BMI, SBP, and DBP adjusting for age and 
maternal educational qualifications. SBP and DBP were 
further adjusted for BMI measured at the same time point. 
We conducted complete-case analysis, as the proportion of 
individuals with missing information was low for age and 
maternal educational level (<2%). All of the metabolites were 
internally standardized before analysis, and we report the RR for 
miscarriage per standard deviation increase in the metabolites, 
after adjusting for the same covariates mentioned above. The 
associations of blood pressure and metabolites with risk of 
miscarriage was also adjusted for the participant’s BMI at 
18 years. We further conducted sensitivity analyses adjusting 
for the women’s smoking status and NEET at age 18 in a 
subsample for which these data were available (approximately 
80%). We also conducted an analysis excluding all women 
with self-reported hypertension, high cholesterol or diabetes at 
the time of the cardiometabolic health assessment, to evaluate 
the potential influence of the subgroup of women who reached 
the threshold for these clinical definitions on the estimated 
associations. As there might be underlying genetic components 
influencing the risk of miscarriage, we also conducted a 
sensitivity analysis adjusting for maternal (G0) number of 
miscarriages. Due to the large number of tests conducted, we 
accounted for multiple testing. The metabolites in the metabo-
lomics panel are strongly correlated. A principal components 
analysis found that the first 17 principal components explained 
around 95% of the variation in the metabolites, and this was 
therefore estimated to be the number of independent tests. The 
conventional p-value threshold of 0.05 was therefore divided 
by 17 to yield a corrected threshold of 0.00318. 
All analyses were conducted using Stata version 15 (Statacorp, 
Texas).
Results
Of the women who attended the 18-year clinic assessment and 
who provided information on their obstetric history (n=2,243), 
465 (21%) had experienced a pregnancy (Extended data, 
Appendix 2)14. The overall risk of miscarriage among women 
who had been pregnant was 22% (n=94 women). Extended 
data, Appendix 314 presents characteristics for the following: 
all female G1 participants, female G1 participants who attended 
the 18 year clinic assessment with a known pregnancy history 
female offspring who had experienced a pregnancy between 
18 and 24 years of age, and female G1 participants included 
in the final analyses. Women with information on any of the 
exposures of interest (n=434) had less educated mothers and 
a higher mean BMI, when compared to all female offspring 
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Age at 18 year follow-up 17.8 (0.4) 17.8 (0.4) 0.463
Maternal education 0.021
Low 96 (28.2) 30 (31.9)
Medium 221 (65.0) 50 (53.2)
High 23 (6.8) 14 (14.9)
Smoking at age 18 0.037
   No 199 (58.5) 46 (48.9)
   Weekly 19 (5.6) 2 (2.1)
   Daily 68 (20.0) 31 (33.0)
   Missing 54 (15.9) 15 (16.0)
Maternal history of miscarriage 0.258
   0 259 (76.2) 68 (72.3)
   1 45 (13.2) 17 (18.1)
   2 or more 23 (6.8) 3 (3.2)
   Missing 13 (3.8) 6 (6.4)
Not in education, training or 
working at age 18 0.360
   No 259 (76.2) 69 (73.4)
   Yes 16 (4.7) 8 (8.5)
   Missing 65 (19.1) 17 (18.1)
BMI at age 18 24.0 (4.8) 23.0 (4.8) 0.101
DBP at age 18 65.0 (6.4) 64.4 (6.1) 0.430
SBP at age 18 114.7 (8.9) 112.5 (8.7) 0.038
in ALSPAC (n=6,838). They were also more likely to smoke 
when they were 18 years of age. The distribution of background 
characteristics according to whether the woman experience a 
miscarriage or not is shown in Table 1.
The mean SBP was 114.2 mmHg (SD 8.9), the mean DBP was 
64.9 mmHg (SD 6.3), while the mean BMI was 23.7 kg/m2 
(SD 4.9). The risk of miscarriage seemed to decrease in a 
linear fashion with increasing SBP (Figure 2). For DBP, 
the smoothed plot of the risk of miscarriage showed some 
evidence of a nonlinear relationship before multivariable 
adjustment (Figure 2), but there was no statistical evidence to 
support a nonlinear association when this was formally tested 
(p-value 0.4). The adjusted RRs for miscarriage was 0.98 
(95% CI: 0.96-1.00) per mmHg higher SBP, and 1.00 (95% CI: 
0.97-1.04) per mmHg higher DBP (Table 2). There was no 
evidence of a difference in risk of miscarriage by BMI 
(Figure 2), with an adjusted RR of 0.96 per kg/m2 increase 
(95% CI: 0.92-1.00) (Table 2).
We examined a large number of metabolites in relation to the 
risk of miscarriage (information available for 154 women). 
Figure 3 shows the associations of components of high-density 
lipoprotein (HDL), low-density lipoprotein (LDL), intermediate- 
density lipoprotein (IDL) and very low-density lipoprotein 
(VLDL)-cholesterol with risk of miscarriage, while Figure 4 
shows the associations of non-lipoprotein metabolic measures 
with miscarriage. A total of nine of the metabolites were 
associated with the risk of miscarriage at the nominal level 
(p-value <0.05). This included concentrations of medium HDL 
cholesterol, total cholesterol in HDL, HDL2 and medium 
HDL cholesterol, concentration of medium HDL cholesterol, 
cholesterol esters in medium HDL cholesterol, total lipids 
in medium HDL cholesterol and phospholipids in large and 
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Figure 2. Risk of miscarriage by 24 years of age according to blood pressure and body-mass index at 18 years among adult 
female offspring in the Avon Longitudinal Study of Parents and Children born between 1991–1992.
Table 2. Association between body-mass index and blood pressure at age 18 with risk of miscarriage 
by age 24 among adult female offspring in the Avon Longitudinal Study of Parents and Children born 











Body-mass index (kg/m2) 424 (89) 23.7 (4.9) 0.96 (0.92-1.01) 0.96 (0.92-1.00) NA
Systolic blood pressure 
(mmHg)
418 (91) 114.2 (8.9) 0.98 (0.96-1.00) 0.97 (0.95-1.00) 0.98 (0.96-1.00)
Diastolic blood pressure 
(mmHg)
418 (91) 64.9 (6.3) 0.99 (0.96-1.02) 0.99 (0.96-1.02) 1.00 (0.97-1.04)
* Adjusted for age and maternal education.
† Adjusted for age, maternal education and BMI at 18 years.
medium HDL cholesterol. These associations with miscarriage 
risk were all positive (adjusted RRs ranged between 1.36 and 
1.44 per standard deviation increase). Mean diameter for LDL 
particles was inversely associated with risk of miscarriage 
(adjusted RR 0.71 per standard deviation increase). None of our 
findings for the metabolites reached our threshold for correc-
tion for multiple testing (p<0.003). There was some evidence 
of nonlinear relationship with three of the components (total 
lipids in small VLDL, cholesterol esters in very small VLDL, 
and phospholipids to total lipids ratio in IDL), with a p-value for 
the likelihood ratio test for nonlinearity ≤0.003. We therefore 
show the smoothed relationships with these three metabolites in 
Extended data, Appendix 414.
The results did not notably change after adjustment for 
smoking or NEET status at age 18 in the subsample with this 
information available (approximately 80% of the total sample) 
(Extended data, Appendices 5–7)14. Only seven women were 
diagnosed with hypertension at 18 years of age, two women were 
diagnosed with high cholesterol, while none were diagnosed 
with diabetes. Excluding women who had hypertension or 
high cholesterol did not change the results. Finally, adjusting 
for the number of miscarriages reported by women’s mothers 
did not change the results (Extended data, Appendices 8–10).
Investigating the potential for selection bias
Restricting analyses to women who became pregnant by age 
24 might introduce selection bias if there are unmeasured 
factors affecting both the likelihood of becoming pregnant and 
the likelihood of miscarriage, as depicted in Extended data, 
Appendix 1114. As demonstrated in the figure, selection bias 
would always induce an association between cardiometabolic 
health and miscarriage, that is in the same direction (i.e. positive 
or inverse) as the association between cardiometabolic health 
and becoming pregnant. However, in our study popula-
tion, we found a positive association between BMI and the 
likelihood of becoming pregnant, and inverse associations of 
HDL-cholesterol, acetate, fatty acid levels and phospholipid 
levels with the likelihood of becoming pregnant (Extended 
data, Appendices 12–14)14. These are in the opposite direction to 
the associations we report between measures of cardiometabolic 
health (BMI, blood pressure, lipids, glucose and insulin) and the 
risk of miscarriage. Restricting the analysis to women who had 
become pregnant at an early age might therefore have biased 
our findings towards the null, but not away from the null.
Finally, we evaluated some known/established relationships in 
our study population to investigate the likelihood of selection 
bias. For example, the observed differences in cardiometabolic 
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Figure  4.  Relative  risks  for  miscarriage  according  to  other  components  of  the  metabolomics  panel  among  adult  female 
offspring in the Avon Longitudinal Study of Parents and Children born between 1991–1992. The Relative risks for miscarriage 
reflect the risk per standard deviation increase in the exposure of interest. The estimates are adjusted for age, maternal educational 
qualifications, and BMI at 18 years. The analysis of metabolites included 265 women (among whom 63 experienced a miscarriage).
Figure 3. Relative risks for miscarriage according to components of lipoproteins among adult female offspring in the Avon 
Longitudinal Study of Parents and Children born between 1991–1992. The Relative risks for miscarriage reflect the risk per standard 
deviation increase in the exposure of interest. The estimates are adjusted for age, maternal educational qualifications, and BMI at 18 years. 
The analysis of metabolites included 265 women (among whom 63 experienced a miscarriage).
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health and risk of miscarriage according to maternal educa-
tion level in the study population were as expected, where 
women who had mothers with a higher educational level had 
lower mean BMI, lower blood pressure, and lower risk of 
miscarriage (Extended data, Appendix 15)14.
Discussion
In this population-based study of young women who experienced 
a pregnancy between the ages of 18 and 24 years, we observed 
no strong evidence to suggest an effect of pre-pregnancy car-
diometabolic health (BMI, blood pressure and metabolites) 
on risk of miscarriage.
A strength of our study is that we had measures on multiple 
aspects of cardiometabolic health before pregnancy. In particu-
lar, the inclusion of the metabolomic profile is unique. To our 
knowledge, there are only a small number of cohorts with simi-
lar data available, as most pregnancy cohorts recruit women 
who are already pregnant and therefore only have measurements 
from early pregnancy, which might not reflect pre-pregnancy 
levels. However, due to the small sample size and resulting 
uncertainty in effect estimates, our findings need to be replicated.
Both the measures of cardiometabolic health and the potential 
confounders (education, smoking, etc.) evaluated could have 
changed between when they were measured at 18 years of 
age and the time of conception. This could have introduced 
misclassification in the exposures and potential residual 
confounding. We did not have information on the gestational 
age or the birthweight of the fetus in cases of fetal death to 
verify and distinguish between what the women reported as a 
stillbirth as opposed to a miscarriage. We had to rely on the 
women´s report. It is therefore possible that there is a degree of 
misclassification between these two groups of fetal deaths.
Our sample consists of women who experienced a pregnancy 
at a relatively young age; mean age at first pregnancy in the 
UK is 3018. The proportion of women with a miscarriage in our 
study population (22%) is slightly higher than what has been 
reported for the general UK population (16%)19. It is unlikely 
that this is driven by selection into the ALSPAC cohort, since 
participants have a higher socio-economic position, and are 
more likely to be Caucasian, compared to the general British 
population20. Our study population (of women who became 
pregnant between the ages of 18 and 24) were substantially 
more likely to smoke (27% smoked daily) compared to women 
between 16 and 19 years of age in 2014 (16%)21. This reflects 
the fact that women who become pregnant at a young age might 
also have a higher likelihood of various risk-seeking behav-
iors. Sampling variation is another potential explanation for the 
higher proportion of miscarriage in our study population. Our 
findings might therefore not be generalizable to all pregnant 
women. A second concern is that restricting our sample to 
pregnant women might result in selection bias as illustrated in 
Extended data, Appendix 1114. The prevalence of smoking at 
18 years of age was higher among women who had experi-
enced a pregnancy. There is some indication that the risk of 
miscarriage increases with smoking during pregnancy20. However, 
through the use of directed acyclic graphs, we demonstrate that 
we are more likely to have underestimated than overestimated 
the associations of interest as a result of this restriction (Extended 
data, Appendix 11)14. Notably, we found that women who had 
experienced a pregnancy were of a similar socio-economic 
background to all female ALSPAC G1 participants (Extended 
data, Appendix 3)14. Lastly, the relationship between the 
cardiometabolic health measures, and the socio-economic 
differences in cardiometabolic health measures and risk of 
miscarriage were in line with the literature16,17.
Several studies indicate that women who are overweight 
or obese have an increased risk of miscarriage7,8. A study 
from the United Kingdom including 844 pregnancies from 
491 women with a history of recurrent miscarriage was one 
of the first to report a nonlinear association between BMI and 
risk of miscarriage, with an almost fourfold increase in the 
risk among underweight women21. Findings from the Danish 
National Birth Cohort (n= 23,821) subsequently provided 
evidence of an increased risk of miscarriage among under-
weight women, albeit of a more modest magnitude (OR 1.24)22. 
We did not find strong evidence of a nonlinear association 
between BMI and miscarriage. This might reflect the age and/or 
BMI distributions in our study sample.
Findings from a preconception cohort revealed that women 
(mean age 29) with higher blood pressure before pregnancy may 
have an increased risk of pregnancy loss23. In contrast, another 
study found evidence of lower blood pressure among women 
(mean age 35 years) with a history of recurrent miscarriages9. 
In our study, we observed very weak evidence of an inverse 
association between SBP at age 18 and the risk of miscarriage, 
while the shape of the association with DBP was less clear.
Our study is the first to evaluate a broader metabolomics panel 
in relation to risk of miscarriage. We observed weak evidence 
of a positive association between total lipids and phospholipids 
in HLD-cholesterol with risk of miscarriage. A previous study 
of women with a history of recurrent miscarriages indicated 
greater levels of phosphatidylserine, and lower levels of phos-
phatidic acid, phosphatidylinositol and ganglioside mannoside 
3 compared to women who had not experienced a miscarriage9. 
Another study reported altered serum lipids profiles among 
women with a threatened miscarriage, including diminished 
concentrations of LDL cholesterol, total cholesterol, and 
phospoholipids24. There are also a few previous studies which 
found that greater Apolipoprotein A-I might is associated with 
an increased likelihood of miscarriage25,26.
Potential explanations for an association between lower BMI 
and higher risk of miscarriage include nutrient deficiencies, 
including anaemia, folate, calcium, and iodine deficiencies, and 
altered placental development and structure27. There is also evi-
dence of metabolic regulators and reprogramming pathways 
of immune cell functions, which might contribute to a greater 
risk of infections and implantation failure among underweight 
women28. Women undergo major hemodynamic changes during 
pregnancy, including increased blood volume, reduced cardiac 
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output, lower heart rate, and decreased stroke volume29. 
It might be that both lower and higher blood pressure before 
pregnancy result in maladaptation to hemodynamic changes, 
and increased risk of miscarriage.
Lipid metabolism may also play a role in ensuring a posi-
tive pregnancy outcome. It is clear that the metabolism of 
phospholipids changes during pregnancy30,31, but we do not 
fully understand if and what impact this may have on ensuring 
a healthy pregnancy. With regard to some of the other specific 
metabolites measured, Apolipoprotein A-I is an immunomodu-
lator, and is shown to inhibit myeloid derived suppressor cell 
recruitment, which is known to regulate maternal pregnancy 
tolerance ensuring an intact pregnancy25,26.
Additional studies are necessary to understand whether the rela-
tionship between pre-pregnancy cardiometabolic health and 
risk of miscarriage differs by maternal age, to clarify whether 
there are certain age groups of women that could benefit from 
medical or lifestyle intervention targeting aspects of cardiometa-
bolic health before they become pregnant to reduce the risk 
of miscarriage. Future studies could also look at the relation-
ship between paternal cardiometabolic health and the risk of 
miscarriage as a negative control.
In conclusion, our findings indicate no strong evidence to support 
a relationship between pre-pregnancy cardiometabolic health and 
risk of miscarriage among young, healthy women who became 
pregnancy before age 24. Our findings need to be replicated in 
larger cohorts with pre-pregnancy measures of cardiometabolic 
health and in a wider age range. 
Data availability
ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to 
the data included in this research article and all other ALSPAC 
data. The datasets presented in this article are linked to ALSPAC 
project number 2234, please quote this project number during 
your application. The ALSPAC variable codes highlighted 
in the dataset descriptions can be used to specify required 
variables.
•    1. Please read the ALSPAC access policy (https://www.bris-
tol.ac.uk/media-library/sites/alspac/documents/researchers/
data-access/ALSPAC_Access_Policy.pdf) which describes 
the process of accessing the data and samples in detail, 
and outlines the costs associated with doing so.
•    2. You may also find it useful to browse our fully search-
able research proposals database (https://proposals.
epi.bristol.ac.uk/), which lists all research projects that 
have been approved since April 2011.
•    3. Please submit your research proposal for consid-
eration by the ALSPAC Executive Committee. You will 
receive a response within 10 working days to advise you 
whether your proposal has been approved.
If you have any questions about accessing data, please email 
alspac-data@bristol.ac.uk.
The ALSPAC data management plan describes in detail the pol-
icy regarding data sharing, which is through a system of managed 
open access. The study website also contains details of all the 




Figshare: 20200813 Supplement.pdf. https://doi.org/10.6084/m9. 
figshare.1280014114.
This file contains the following extended data:
•    Appendix 1. Correlation between cardiometabolic health 
measures at 18 years of age among adult female off-
spring in the Avon Longitudinal Study of Parents and 
Children born between 1991–1992.
•    Appendix 2. Illustration of study population among 
adult female offspring in the Avon Longitudinal Study of 
Parents and Children born between 1991–1992.
•    Appendix 3. Distribution of female G1 participant’s 
background characteristics according to follow-up infor-
mation available among adult female offspring in the 
Avon Longitudinal Study of Parents and Children born 
between 1991–1992.
•    Appendix 4. Risk of miscarriage by metabolites for which 
there was some evidence of a nonlinear relationship 
among adult female offspring in the Avon Longitudinal 
Study of Parents and Children born between 1991–1992.
•    Appendix 5. Association between body-mass index and 
blood pressure at age 18with risk of miscarriage by 
age 24 among individuals with information on educa-
tional/employment status at 18 years among adult female 
offspring in the Avon Longitudinal Study of Parents 
and Children born between 1991–1992.
•    Appendix 6. Relative risks for miscarriage by 24 years 
of age according to components of lipoproteins among 
adult female offspring in the Avon Longitudinal Study 
of Parents and Children born between 1991–1992.
•    Appendix 7. Relative risks for miscarriage by 24 years of 
age according to other components of the metabolomics 
panel among adult female offspring in the Avon Lon-
gitudinal Study of Parents and Children born between 
1991–1992.
•    Appendix 8. Directed acyclic graphs depicting four dif-
ferences scenarios for how an unmeasured confounder 
might influence the association between cardiometabolic 
health and risk of miscarriage.
•    Appendix 9. Association between body-mass index 
and blood pressure at age 18 with likelihood of becom-
ing pregnant by 24 years of age among adult female off-
spring in the Avon Longitudinal Study of Parents and 
Children born between 1991̵1992.
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This interesting study utilising data collected from the G1 participants of the ALSPAC cohort 
found no association between cardiometabolic factors at age 18 and risk of miscarriage. 
The study design and analyses are appropriate taking account of the issue of multiple 
testing. 
 
Comment 1: However, the very small sample size and younger age of the participants 
mean that the generalizability of the findings is limited. 
Response comment 1: We acknowledge the fact that the G1 participants in ALSPAC are 
relatively  young. This limitation is acknowledged in the discussion. 
 
Discussion (p. 12-13): 
“Our sample consists of women who experienced a pregnancy at a relatively young age; 
mean age at first pregnancy in the UK is 30.[6] Our findings might therefore not be 
generalizable to all pregnant women.  A second concern is that restricting our sample to 
pregnant women might result in selection bias as illustrated in Appendix 8. The prevalence 
of smoking at 18 years of age was higher among women who had experienced a 
pregnancy. There is some indication that the risk of miscarriage increases with smoking 
during pregnancy.[7] However, through the use of directed acyclic graphs, we demonstrate 
that we are more likely to have underestimated than overestimated the associations of 
interest as a result of this restriction (Appendix 8). Notably, we found that women who had 
experienced a pregnancy were of a similar socio-economic background to all female ALSPAC 
G1 participants (Appendix 3).  Lastly, the relationships between cardiometabolic health 
measures, and the socio-economic differences in cardiometabolic health measures and risk 
of miscarriage were in line with the literature.[8, 9] ” 
 
Comment 2: The authors report a higher risk of miscarriage in this cohort - 22% vs 15% 
in the general population despite the low risk age. Could this perhaps be explained by 
the higher prevalence of smoking, lower socioeconomic status and other 
characteristics that may have introduced a selection bias?  
 
Response comment 2: As seen in many cohort studies, and in line with the population 
structure in the south west of the UK, participants in ALSPAC are actually of a higher socio-
economic position and more likely to be Caucasian compared to the general British 
population. In response to this comment, we have added the following sentence into the 
discussion. 
 
Discussion (p. 12-13): 
“The proportion of women with a miscarriage in our study population (22%) is slightly 
higher than what has been reported for the general UK population (16%).[10] It is unlikely 
that this is driven by selection into the ALSPAC cohort, since participants have a higher 
socio-economic position, and are more likely to be Caucasian, compared to the general 
British population.[11] Our study population (of women who became pregnant between the 
ages of 18 and 24) were substantially more likely to smoke (27% smoked daily) compared to 
women between 16 and 19 years of age in 2014 (16%).[12] This reflects the fact that women 
who become pregnant at a young age might also have a higher likelihood of various risk-
seeking behaviors. Sampling variation is another potential explanation for the higher 
proportion of miscarriage in our study population.” 
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Comment 3: I would have liked to see the BMI, blood pressure, smoking etc. compared 
between those with and without miscarriage in Table 1.  
 
Response comment 3: We have included a new table 1 illustrating the distribution of 
background characteristics and main cardiometabolic measures according to whether the 
woman experienced a miscarriage or not. 
 
Comment 4: The authors state that pregnancy information was self reported and 
therefore subject to reporting bias. Why was pregnancy information not obtained by 
data linkage through REDCAP? 
 
Response comment 4: We apologise, but we are not sure that we follow this comment. 
Participants reported their obstetric history on xx questionnaires between the ages of 18 
and 24 and at clinic assessments. RedCap is the data management system used in ALSPAC. 
We did not require linkage to external data sources such as medical records. 
 
Comment 5: Are the results presented adjusted for all covariates including smoking 
(where 20% data were missing? 
Response comment 5: In the original draft, we did not show the results from the sensitivity 
analysis adjusting for the woman´s own smoking status. We now show the results from a 
combined sensitivity analysis both adjusting for own smoking status and NEET status at 18 
years of age (Appendix 5-7). The results have been updated as follows. 
 
Results (p. 10): 
“The results did not notably change after adjustment for smoking or NEET status at age 18 
in the subsample with this information available (approximately 80% of the total sample) 
(Appendix 5-7).” 
 
Comment 6: There is an association between maternal history of miscarriage and risk 
of miscarriage in their daughters (Woolner, 2020). As this cohort can possibly look at 
this association, it would have been good to present the interplay of genetic versus 
lifestyle factors in having a miscarriage. 
  
Response comment 6: Thank you for raising this interesting issue. We have included an 
additional sensitivity analysis also adjusting for the mother´s report of miscarriages. This 
sensitivity analysis is now described in the methods and results. 
Methods (p. 7): 
“As there might be underlying genetic components influencing the risk of miscarriage, we 
also conducted a sensitivity analysis adjusting for maternal (G0) number of miscarriages.” 
Results (p. 10): 
“Finally, adjusting for the number of miscarriages reported by women’s mothers did not 
change the results (Appendix 8-10).” 
 
Comment 7: My main concern is that the cohort is still too young to study this type of 
association as majority have not had a pregnancy yet and those who have are a very 
select group. Therefore the findings may change if the same analysis is repeated in 
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the same cohort after another 5 years. I would urge the authors to wait till the cohort 
matures. 
 
Response comment 7: We understand the reviewer´s concern. This is why we conducted an 
extensive evaluation of the potential influence of a selection bias. We agree that the 
research question should be re-visited after the cohort has matured a bit more. However, 
this will take time, and we think that there is value to presenting the results as we see them 
so far. In response to this comment, we have tempered our conclusion as follows. 
 
Abstract (p. 2): 
“Our findings indicate no strong evidence to support a relationship between pre-pregnancy 
cardiometabolic health and risk of miscarriage in young, healthy women who became 
pregnant before age 24. Future studies are necessary that are able to evaluate this question 
among women who have a wider age range.” 
 
Discussion (p. 15): 
“In conclusion, our findings indicate no strong evidence to support a relationship between 
pre-pregnancy cardiometabolic health and risk of miscarriage among young, healthy 
women who became pregnancy before age 24. Our findings need to be replicated in larger 
cohorts with pre-pregnancy measures of cardiometabolic health and in a wider age range.”  
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Maria Morales-Suarez-Varela  
Unit of Public Health and Environmental Care, Department of Preventive Medicine, University of 
Valencia, Valencia, Spain 
Thank you very much for allowing me to review the research article entitled “Cardiometabolic 
health during early adulthood and risk of miscarriage: a prospective study”. 
The objective of this work was to investigate the risk of miscarriage according to pre-pregnancy 
cardiometabolic health. Concretely to examine whether pre-pregnancy BMI, blood pressure, 
fasting insulin, and metabolomic profile at age 18 are associated with miscarriage risk in young, 
healthy women who became pregnant before 24 years of age. 
Methodologically the study is carried out on participants in the Avon Longitudinal Study of Parents 
and Children (ALSPAC) (UK). 
Concluding that pre-pregnancy cardiometabolic health in late adolescence was not associated 
with miscarriage risk in young, healthy women who became pregnant before age 24. 
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Comments: 
It is a study with a very important objective today, as we see an increase in early pregnancies. 
 
Introduction:  
It should be more extensive, especially the concept to be studied "risk of miscarriage" and the 
current knowledge on this topic in relation to the cardiometabolic factors studied should be 
defined. 
 
Methodology and results: 
A figure with a diagram of the study participants would facilitate understanding (G1 and G2). 
Defining the studied concept "risk of miscarriage" may or may not be an abortion, and if it can be 
included at what time of pregnancy, first trimester, Second ... 
The measurements used are at 18 years of age, but these do not have to be the same pre-
pregnancy, these two moments should be evaluated in the parameters studied. The same 
happens with the educational level, the socioeconomic level, and the smoking habit. 
A table comparing the characteristics of women with "risk of miscarriage" and women who 
successfully terminated their pregnancy would be essential to understand the study. In the 
statistical analysis, it should be more clearly indicated when crude RR is used and when adjusted 
and why covariates. 
In the results, indicate the statistically significant results. Adjusted RR would be convenient, since 
"risk of miscarriage" is multifactorial. 
 
Discussion: 
The authors are aware of the strengths and weaknesses of the study. 
 
Overall assessment: 
The study raises a very interesting objective and uses a prominent project database. The design 
should assess a comparison between the situation of pregnant women at 18 years of age and 
their situation prior to pregnancy. However, the available sample size is small for the proposed 
objective, so its conclusions are risky.
 
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
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Reviewer Expertise: Epidemiology
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 30 Jan 2021
Maria C. Magnus, Norwegian Institute of Public Health, Oslo, Norway 
Maria Morales-Suarez-Varela, Unit of Public Health and Environmental Care, Department 
of Preventive Medicine, University of Valencia, Valencia, Spain  
 
Thank you very much for allowing me to review the research article entitled 
“Cardiometabolic health during early adulthood and risk of miscarriage: a prospective 
study”. 
 
The objective of this work was to investigate the risk of miscarriage according to pre-
pregnancy cardiometabolic health. Concretely to examine whether pre-pregnancy BMI, 
blood pressure, fasting insulin, and metabolomic profile at age 18 are associated with 
miscarriage risk in young, healthy women who became pregnant before 24 years of age. 
Methodologically the study is carried out on participants in the Avon Longitudinal Study of 
Parents and Children (ALSPAC) (UK). 
Concluding that pre-pregnancy cardiometabolic health in late adolescence was not 
associated with miscarriage risk in young, healthy women who became pregnant before 
age 24. 
Comments: 





It should be more extensive, especially the concept to be studied "risk of miscarriage" 
and the current knowledge on this topic in relation to the cardiometabolic factors 
studied should be defined. 
 
Response comment 1: We have expanded the introduction as requested. 
 
Introduction (p. 3): 
“Several studies have found that women who are overweight or obese have an increased 
risk of miscarriage, while others report a potential nonlinear relationship with an increased 
risk in underweight women as well.[1, 2]  There is conflicting evidence of a relationship 
between blood pressure and risk of miscarriage, with one preconception cohort indicating a 
positive association with pregnancy loss, [3] while another study reported a lower blood 
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pressure among women with a history of recurrent miscarriage.[4] The evidence of a 
relationship between lipid levels and risk of miscarriage is scarce. Animal studies support 
the notion that treatment of high cholesterol with statins may reduce the risk of 
miscarriage.[5]” 
 
Methodology and results 
Comment 2: A figure with a diagram of the study participants would facilitate 
understanding (G1 and G2).  
 
Response comment 2: We have created a figure illustrating the design of the study and the 
generations participating in ALSPAC (see Figure 1). 
 
Comment 3: Defining the studied concept "risk of miscarriage" may or may not be an 
abortion, and if it can be included at what time of pregnancy, first trimester, Second...  
 
Response comment 3: We have incorporated the following limitation in the discussion. 
 
Methods (p. 6): 
“The outcome of any pregnancies were classified as “baby born alive”, “baby born stillborn”, 
“termination of an unwanted pregnancy”, “termination for medical reasons” and 
“miscarriage”. No additional information on the gestational week when the pregnancy 
ended or the birthweight of the offspring was available to better distinguish between 
stillbirth and miscarriage.” 
 
Discussion (p. 12): 
“We did not have information on the gestational age or the birthweight of the fetus in cases 
of fetal death to verify and distinguish between what the women reported as a stillbirth as 
opposed to a miscarriage. We had to rely on the women´s report. It is therefore possible 
that there is a degree of misclassification between these two groups of fetal deaths.” 
 
Comment 4: The measurements used are at 18 years of age, but these do not have to 
be the same pre-pregnancy, these two moments should be evaluated in the 
parameters studied. The same happens with the educational level, the socioeconomic 
level, and the smoking habit. 
 
Response comment 4: Thank you for raising these important points. We agree that both the 
measures of pre-pregnancy cardiometabolic health and the potential confounders 
evaluated may have changed between the time of measurement and conception. This has 
now been acknowledged as a limitation. 
 
Discussion (p. 12): 
“Both the measures of cardiometabolic health and the potential confounders (education, 
smoking, etc.) evaluated could have changes between when they were measured at 18 
years of age and the time of conception. This could have introduced misclassification in the 
exposures and potential residual confounding.” 
 
Comment 5: A table comparing the characteristics of women with "risk of 
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miscarriage" and women who successfully terminated their pregnancy would be 
essential to understand the study. In the statistical analysis, it should be more clearly 
indicated when crude RR is used and when adjusted and why covariates. 
 
Response comment 5: In response to this comment, we have created a new Table 1 which 
illustrates the distribution of background characteristics among women who did and did 
not experience a miscarriage. 
 
Results (p. 9): 
“The distribution of background characteristics according to whether the woman experience 
a miscarriage or not is shown in Table 1.” 
 
Comment 6: In the results, indicate the statistically significant results. Adjusted RR 
would be convenient, since "risk of miscarriage" is multifactorial. 
 
Response comment 6: All results presented are adjusted. In response to this comment, we 
have carefully gone through the results to clarify this. 
 
Discussion: 
Comment 7: The authors are aware of the strengths and weaknesses of the study. 
 
Response comment 7: We have elaborated a bit more on the weaknesses of the study in 
response to your comments and those of the other reviewer (see p. 12-13). 
 
Overall assessment: 
Comment 8: The study raises a very interesting objective and uses a prominent project 
database. The design should assess a comparison between the situation of pregnant 
women at 18 years of age and their situation prior to pregnancy. However, the 
available sample size is small for the proposed objective, so its conclusions are risky. 
 
Response comment 8: We acknowledge the fact that ALSPAC G1 offspring (those born in 
1991 and 1992) are still relatively young, and as a result only a small proportion of them 
have started having children of their own. In response to this comment and those of the 
other reviewer, we have tempered our conclusion as follows. 
 
Abstract (p. 2): 
“Our findings indicate no strong evidence to support a relationship between pre-pregnancy 
cardiometabolic health and risk of miscarriage in young, healthy women who became 
pregnant before age 24. Future studies are necessary that are able to evaluate this question 
in samples with a wider age range.” 
 
Discussion (p. 15): 
“In conclusion, our findings indicate no strong evidence to support a relationship between 
pre-pregnancy cardiometabolic health and risk of miscarriage among young, healthy 
women who became pregnancy before age 24. Our findings need to be replicated in larger 
cohorts with pre-pregnancy measures of cardiometabolic health and in a wider age range.”  
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